Atlas Trials

Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy

Clinical trial NCT07256002 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07256002
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer (NSCLC)
Start date
2020-01-01
Primary completion
2023-12-01
Enrollment
10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.